Clinical Trials
Showing trials with last updates posted in 2024.
500
Participants
Uremic Toxins and Outcomes in Chronic Kidney Disease
Study Type:
OBSERVATIONAL
Last Updated:
2024-12-03
Start Date:
2018-05-01
Completion:
2024-12-31
Conditions
Chronic Kidney Diseases
No Results Yet
20
Participants
Electrical Stimulation in Denervated Muscles of the Upper Limbs
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-09-01
Completion:
2020-12-31
Conditions
Tetraplegia
Interventions
OTHER
No Results Yet
60
Participants
Comparison Efficiency of Oral Etoricoxib Versus Intravenous Fentanyl on Post Operative Pain in Curettage Under TIVA
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-11-01
Completion:
2019-04-01
Conditions
Abnormal Uterine Bleeding
Interventions
PROCEDURE
No Results Yet
217
Participants
SVT-15652 Otic Solution for the Treatment of Otomycosis
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2020-02-27
Completion:
2021-10-25
Conditions
Otomycosis
Interventions
DRUG
45
Participants
Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral Component
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2009-08-01
Completion:
2023-05-22
Conditions
Avascular Necrosis of Hip
Osteoarthritis, Hip
Rheumatoid Arthritis
Inflammatory Arthritis
Post-traumatic; Arthrosis
Interventions
DIAGNOSTIC_TEST
315
Participants
Trifluridin/tipirACil in MeTastatIc Colorectal Cancer
Study Type:
OBSERVATIONAL
Last Updated:
2024-12-03
Start Date:
2018-06-25
Completion:
2021-08-02
Conditions
Metastatic Colorectal Cancer
Interventions
DRUG
No Results Yet
365
Participants
Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-09-05
Completion:
2023-07-10
Conditions
Primary IgA Nephropathy
Interventions
DRUG
50
Participants
Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-07-01
Completion:
2019-11-30
Conditions
Metformin
CA Endometrium
Interventions
DRUG
No Results Yet
194
Participants
Cardiac Sarcoidosis Randomized Trial
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2019-01-15
Completion:
2025-12-31
Conditions
Cardiac Sarcoidosis
Sarcoidosis
Interventions
DRUG
No Results Yet
800
Participants
Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy
Study Type:
OBSERVATIONAL
Last Updated:
2024-12-03
Start Date:
2018-04-11
Completion:
2020-12-31
Conditions
Lung Cancer
No Results Yet
100
Participants
Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-07-30
Completion:
2023-03-20
Conditions
Metastatic Colorectal Cancer
Interventions
DRUG
No Results Yet
25
Participants
The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-08-30
Completion:
2022-11-18
Conditions
Non-small Cell Lung Cancer, NSCLC
Interventions
DRUG
135
Participants
Pertussis Immunization During Pregnancy & HIV Infection
Study Type:
OBSERVATIONAL
Last Updated:
2024-12-03
Start Date:
2017-03-01
Completion:
2019-06-01
Conditions
Immunization; Infection
Pertussis
HIV-1-infection
Pregnancy
Interventions
BIOLOGICAL
No Results Yet
12
Participants
NeSST2: The Development of a Noninvasive Short Synacthen Test
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2012-10-12
Completion:
2025-12-01
Conditions
Adrenal Suppression
Interventions
DRUG
No Results Yet
670
Participants
Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors
Study Type:
OBSERVATIONAL
Last Updated:
2024-12-03
Start Date:
2018-04-16
Completion:
2033-04-16
Conditions
Carcinoid Heart Disease
Interventions
OTHER
No Results Yet
45
Participants
OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-05-21
Completion:
2021-11-03
Conditions
Triple Negative Breast Cancer
Interventions
DRUG
797
Participants
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-04-24
Completion:
2023-07-10
Conditions
Non-small Cell Lung Cancer
Interventions
BIOLOGICAL
DRUG
50
Participants
A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-05-02
Completion:
2026-03-29
Conditions
VHL - Von Hippel-Lindau Syndrome
VHL Gene Mutation
VHL Syndrome
VHL Gene Inactivation
VHL-Associated Renal Cell Carcinoma
VHL-Associated Clear Cell Renal Cell Carcinoma
Interventions
DRUG
No Results Yet
632
Participants
An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants
Study Type:
OBSERVATIONAL
Last Updated:
2024-12-03
Start Date:
2018-07-31
Completion:
2035-07-31
Conditions
Breast Implant; Complications
Quality of Life
Satisfaction
Interventions
DEVICE
No Results Yet
17
Participants
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-07-20
Completion:
2023-10-31
Conditions
Kidney Cancer
Interventions
BIOLOGICAL
92
Participants
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2017-07-24
Completion:
2026-06-30
Conditions
Patellofemoral Pain Syndrome
Interventions
DEVICE
OTHER
No Results Yet
49
Participants
A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2017-07-06
Completion:
2023-10-13
Conditions
Type 1 Diabetes Mellitus With Hypoglycemia
Interventions
COMBINATION_PRODUCT
50
Participants
Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-05-14
Completion:
2019-07-08
Conditions
Metastatic Non-Small Cell Lung Carcinoma
Interventions
DRUG
No Results Yet
81
Participants
Post-Market Clinical Follow-up Study with ASPIREX®S to Assess the Safety and Effectiveness in the Treatment of DVT
Study Type:
OBSERVATIONAL
Last Updated:
2024-12-03
Start Date:
2017-04-03
Completion:
2021-12-30
Conditions
Deep Vein Thrombosis
Bypass Complication
Dialysis Shunt
Stent Occlusion
No Results Yet
365
Participants
E-alcohol Therapy - an Evaluation of Alcohol Therapy Delivered Via Video Conference
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-01-22
Completion:
2021-08-01
Conditions
Problematic Alcohol Use
Interventions
BEHAVIORAL
No Results Yet
66
Participants
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2017-03-21
Completion:
2025-12-31
Conditions
Recurrent Prostate Cancer
Interventions
DRUG
DEVICE
No Results Yet
221
Participants
Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2015-08-31
Completion:
2020-03-31
Conditions
Asthma
Interventions
BEHAVIORAL
40
Participants
99Tc-MDP Treatment for Knee Osteoarthritis
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2017-09-01
Completion:
2025-12-30
Conditions
Treatment Outcome
Interventions
DRUG
No Results Yet
250
Participants
PRospective Multiple Myeloma Impact Study
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2018-02-27
Completion:
2022-04-18
Conditions
Multiple Myeloma
Interventions
DEVICE
No Results Yet
29
Participants
Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2017-04-24
Completion:
2021-09-01
Conditions
Gastric Cancer
Interventions
DRUG
No Results Yet
35
Participants
Study of Recombinant Adenovirus AdVince in Patients With Neuroendocrine Tumors; Safety and Efficacy
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2016-03-31
Completion:
2025-08-31
Conditions
Neuroendocrine Tumors
Interventions
DRUG
No Results Yet
120
Participants
Pain and Anxiety During Extracorporeal Shock Wave Lithotripsy
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2014-04-30
Completion:
2014-09-30
Conditions
Urinary Tract Stones
Pain
Anxiety
Interventions
OTHER
No Results Yet
40
Participants
Patient-derived Xenograft Models of Tumor From Patients With Head and Neck Cancer
Study Type:
OBSERVATIONAL
Last Updated:
2024-12-03
Start Date:
2015-09-30
Completion:
2025-12-31
Conditions
Squamous Cell Carcinoma of the Head and Neck
Interventions
PROCEDURE
No Results Yet
236
Participants
The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2015-06-30
Completion:
2022-04-30
Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG
RADIATION
No Results Yet
151
Participants
Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2014-10-23
Completion:
2021-07-26
Conditions
Triple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mm
Interventions
PROCEDURE
No Results Yet
25
Participants
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMS
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2014-10-31
Completion:
2017-05-31
Conditions
Multiple Sclerosis
Interventions
DRUG
No Results Yet
265
Participants
Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2013-10-09
Completion:
2017-08-04
Conditions
Acute Myeloid Leukemia
Interventions
DRUG
41
Participants
Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2013-11-04
Completion:
2024-05-03
Conditions
B-Cell Non-Hodgkin Lymphoma
Hematopoietic and Lymphoid Cell Neoplasm
Leukemia
Lymphoma
Plasma Cell Myeloma
T-Cell Non-Hodgkin Lymphoma
Interventions
BIOLOGICAL
DRUG
55
Participants
Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated with Peginterferon Alpha-2a and Ribavirin
Study Type:
OBSERVATIONAL
Last Updated:
2024-12-03
Start Date:
2012-07-31
Completion:
2017-02-17
Conditions
Chronic Hepatitis C
Interventions
DEVICE
No Results Yet
34
Participants
Eltrombopag for Moderate Aplastic Anemia
Study Type:
INTERVENTIONAL
Last Updated:
2024-12-03
Start Date:
2011-04-01
Completion:
2018-03-30
Conditions
Moderate Aplastic Anemia
Unilineage Bone Marrow Failure Disorders
Interventions
DRUG
Showing 40 trials per page